181 related articles for article (PubMed ID: 35242858)
1. Comprehensive genomic profiling and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the stomach and parotid gland.
Cui Q; Wu H; Zeng W; Du H; Xiao Z; Hou T; Li M; Li Y; Zhang Z; Li Z
Ann Transl Med; 2022 Jan; 10(1):13. PubMed ID: 35242858
[TBL] [Abstract][Full Text] [Related]
2. Primary pulmonary lymphoepithelioma-like carcinoma with positive expression of Epstein-Barr virus and PD-L1: A case report.
Sasaki A; Kato T; Ujiie H; Cho Y; Sato M; Kaji M
Int J Surg Case Rep; 2021 Feb; 79():431-435. PubMed ID: 33529823
[TBL] [Abstract][Full Text] [Related]
3. RNA Expression Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder Reveals a Basal-Like Molecular Subtype.
Manocha U; Kardos J; Selitsky S; Zhou M; Johnson SM; Breslauer C; Epstein JI; Kim WY; Wobker SE
Am J Pathol; 2020 Jan; 190(1):134-144. PubMed ID: 31610173
[TBL] [Abstract][Full Text] [Related]
4. Correlation and prognostic significance of PD-L1 and P53 expression in resected primary pulmonary lymphoepithelioma-like carcinoma.
Yu XY; Zhang XW; Wang F; Lin YB; Wang WD; Chen YQ; Zhang LJ; Cai L
J Thorac Dis; 2018 Mar; 10(3):1891-1902. PubMed ID: 29707344
[TBL] [Abstract][Full Text] [Related]
5. Metastatic stomach lymphoepithelioma-like carcinoma and immune checkpoint inhibitor therapy: A case report.
Chen GF; Wang J; Yan Y; Xu S; Chen J
World J Gastrointest Surg; 2024 May; 16(5):1436-1442. PubMed ID: 38817283
[TBL] [Abstract][Full Text] [Related]
6. Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma.
Jiang L; Wang L; Li PF; Zhang XK; Chen JW; Qiu HJ; Wu XD; Zhang B
Onco Targets Ther; 2015; 8():1451-7. PubMed ID: 26109869
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival.
Fang W; Hong S; Chen N; He X; Zhan J; Qin T; Zhou T; Hu Z; Ma Y; Zhao Y; Tian Y; Yang Y; Xue C; Tang Y; Huang Y; Zhao H; Zhang L
Oncotarget; 2015 Oct; 6(32):33019-32. PubMed ID: 26361045
[TBL] [Abstract][Full Text] [Related]
8. [Clinical Analysis of Primary Pulmonary Lymphoepithelioma-like Carcinoma in 8 Patients].
Zhao H; Chen J
Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):168-175. PubMed ID: 32209185
[TBL] [Abstract][Full Text] [Related]
9. Clinical observation of pulmonary lymphoepithelioma-like carcinoma.
Sha Z; Wei Y; Gao T; Luo Y; Chen J; Li T; Hu L; Niu X; Lin Z; Lv W; Pei X
J Thorac Dis; 2021 Oct; 13(10):5683-5690. PubMed ID: 34795918
[TBL] [Abstract][Full Text] [Related]
10. Molecular and Clinical Characteristics of Primary Pulmonary Lymphoepithelioma-Like Carcinoma.
Fan Y; Shan Q; Gong J; Qin J; Lu H
Front Mol Biosci; 2021; 8():736940. PubMed ID: 34760925
[No Abstract] [Full Text] [Related]
11. Distinct Molecular Landscape of Epstein-Barr Virus Associated Pulmonary Lymphoepithelioma-Like Carcinoma Revealed by Genomic Sequencing.
Chau SL; Tong JH; Chow C; Kwan JS; Lung RW; Chung LY; Tin EK; Wong SS; Cheung AH; Lau RW; Ng CS; Mok TS; Lo KW; To KF
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726920
[TBL] [Abstract][Full Text] [Related]
12. Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy.
Xu Y; Li H; Huang Z; Chen K; Yu X; Sheng J; Zhang HH; Fan Y
Transl Lung Cancer Res; 2020 Dec; 9(6):2367-2379. PubMed ID: 33489799
[TBL] [Abstract][Full Text] [Related]
13. Partial absence of PD-1 expression by tumor-infiltrating EBV-specific CD8
Simoni Y; Becht E; Li S; Loh CY; Yeong JPS; Lim TKH; Takano A; Tan DSW; Newell EW
Clin Transl Immunology; 2020; 9(9):e1175. PubMed ID: 32995000
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.
Min BH; Tae CH; Ahn SM; Kang SY; Woo SY; Kim S; Kim KM
Gastric Cancer; 2016 Jul; 19(3):852-9. PubMed ID: 26265391
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer landscape of
Kelly AD; Murugesan K; Kuang Z; Montesion M; Ross JS; Albacker LA; Huang RSP; Lin DI; Demirci U; Creeden J
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34815356
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy.
Chang YL; Yang CY; Lin MW; Wu CT; Yang PC
Lung Cancer; 2015 Jun; 88(3):254-9. PubMed ID: 25862146
[TBL] [Abstract][Full Text] [Related]
17. Lymphoepithelioma-like carcinoma: a distinct type of gastric cancer.
Park S; Choi MG; Kim KM; Kim HS; Jung SH; Lee JH; Noh JH; Sohn TS; Bae JM; Kim S
J Surg Res; 2015 Apr; 194(2):458-463. PubMed ID: 25592274
[TBL] [Abstract][Full Text] [Related]
18. Anti-PD-1 antibodies, a novel treatment option for advanced chemoresistant pulmonary lymphoepithelioma carcinoma.
Zhou N; Tang H; Yu S; Lin Y; Wang Y; Wang Y
Front Immunol; 2022; 13():1001414. PubMed ID: 36561745
[TBL] [Abstract][Full Text] [Related]
19. Non-Epstein-Barr virus-associated double primary lymphoepithelioma-like carcinoma of the esophagus and stomach: a case report and literature review.
Xue J; Yu H; Yan J; Ren N; Yang Y; Wang X; Wang Y
Int J Clin Exp Med; 2015; 8(6):10051-7. PubMed ID: 26309699
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial Carcinomas.
Huang RSP; Haberberger J; Harries L; Severson E; Duncan DL; Ferguson NL; Hemmerich A; Edgerly C; Murugesan K; Xiao J; McEwan D; Holmes O; Hiemenz M; Venstrom J; Elvin JA; Creeden J; Lin DI; Ross JS; Ramkissoon SH
Oncologist; 2021 May; 26(5):375-382. PubMed ID: 33687775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
